The emerging class of GLP-1 receptor agonist and GIP co-agonist medications, such as tirzepatide, semaglutide, and the newly introduced retatrutide, provide significant advances in the treatment . https://researchpeptidesusa981897.technoblogging.com/64118/semaglutide-the-comparative-review